Description: Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers medical treatment and health services. The company was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Luoxin Pharmaceuticals Group Stock Co., Ltd. is based in Linyi, China.
Home Page: www.luoxin.cn
Building 1 and 2
Shanghai,
201210
China
Phone:
86 576 86331298
Officers
Name | Title |
---|---|
Mr. Zhenteng Liu | Board Sec. & Chairman |
Mr. Baoqi Liu | GM & Director |
Ms. Minghua Li | Director |
Ms. Xian Chen | Financial Mang. |
Mr. Bohong Sun | Deputy Gen. Mang. |
Mr. Meng Li | Deputy Gen. Mang. |
Ms. Lijun Dong | Deputy Gen. Mang. |
Ms. Xian Chen | Financial Mang. |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
GIC Sector: | Industrials |
---|---|
GIC Group: | Capital Goods |
GIC Industry: | Machinery |
GIC Sub-Industry: | Industrial Machinery |
Forward PE: | 0 |
---|---|
Trailing PE: | 33.7826 |
Price-to-Book MRQ: | 2.3558 |
Price-to-Sales TTM: | 1.8925 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 6393 |